Danaparoid and hypokalaemia Patient Reports February 12, 2012

Danaparoid Side Effects Report #5116966-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #5024835-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, DOPAMINE, OMEPRAZOLE, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #4873367-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2005. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, platelet count decreased, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, FUROSEMIDE, OMEPRAZOLE, GLYCERYL. Patient died.

Danaparoid Side Effects Report #4968091-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, hypokalaemia, melaena, platelet count decreased, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.


Danaparoid Side Effects Report #5020297-7
Danaparoid side effect was reported by a Consumer or non-health professional from ARMENIA on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, cerebral haemorrhage, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020449-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5797285-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on June 16, 2008. Male patient, 80 years of age, was diagnosed with hypokalaemia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: colitis ulcerative, hypokalaemia, inflammation, rectal haemorrhage, splenectomy. Danaparoid dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE LYSINE, WARFARIN, POTASSIUM CHLORIDE, CLOPIDOGREL BISULPHATE, IRBESARTAN, NITRENDIPINE, FLUVASTATIN, LOPERAMIDE OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5984619-2
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Nov 24, 2008. Male patient, 80 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: colitis ulcerative, hypokalaemia, inflammation, living in residential institution, rectal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE LYSINE, WARFARIN, POTASSIUM CHLORIDE, CLOPIDOGREL BISULPHATE, IRBESARTAN, NITRENDIPINE, FLUVASTATIN, LOPERAMIDE OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5989264-0
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Nov 25, 2008. Male patient, 80 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: colitis ulcerative, hypokalaemia. Danaparoid dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE LYSINE, WARFARIN, POTASSIUM CHLORIDE, CLOPIDOGREL BISULPHATE, IRBESARTAN, NITRENDIPINE, FLUVASTATIN, LOPERAMIDE OXIDE. Patient was hospitalized. Patient recovered.